LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo Software
Open App
ClosedPublished 9 Mar 2023

invoX /
F-star

invoX Pharma Limited completes F-star Therapeutics acquisition

Price
$161m
Stage
Closed
Buy side: invoX
Buy sideinvoX
Target: F-star
TargetF-star
Source · 9 Mar 2023
See the source
Buy side: invoX
Buy sideinvoX
Target: F-star
TargetF-star
01 / BuyerinvoX
02 / TargetF-star
01

What happened

invoX Pharma Limited completed its acquisition of F-star Therapeutics, Inc. on March 8, 2023. The transaction involved aggregate cash consideration of approximately $161 million, or $7.12 per share.

F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company pioneering bispecifics in immunotherapy.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

invoX Pharma Limited completes F-star Therapeutics acquisition

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.